rxstat › Classes › Antiinflammatory Agents

Antiinflammatory Agents: shortage status in Canada

6 of the 9 antiinflammatory agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Bromfenac (Prolensa) Partial shortage 1 of 2 reported products affected · est. return Jun 25, 2027 Dexamethasone (Maxidex) Partial shortage 1 of 12 reported products affected · est. return Nov 13, 2026 Diclofenac (Voltaren) Partial shortage 4 of 34 reported products affected · est. return Jan 8, 2027 Fluorometholone (Fml) Partial shortage 1 of 2 reported products affected · est. return Nov 11, 2026 Ketorolac Tromethamine (Toradol) Partial shortage 5 of 13 reported products affected · est. return Jan 29, 2027 Nepafenac (Nevanac) Partial shortage 1 of 2 reported products affected · est. return Nov 15, 2026 Difluprednate (Durezol) No current shortage Fluorometholone (Flarex) Discontinued 0 of 1 reported products affected Prednisolone (Pred Mild) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.